The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Site maintenance Monday, July 8th, 2024. Please note that access to some content and account information will be unavailable on this date.
ArticleNo Access

AKATHISIA: THE SYNDROME OF MOTOR RESTLESSNESS

Published Online:https://doi.org/10.1176/ajp.116.4.337

1. The syndrome of akathisia has been defined and described. It appears to be a manifestation of the Parkinson syndrome.

2. Two cases of akathisia are reported. They both occurred during administration of phenothiazine tranquilizing drugs, and were relieved by changing or stopping the drug and by adding an anti-Parkinson drug. No attempt was made to determine the necessity for adding the anti-Parkinson drug when the tranquilizer was changed, though Kruse(4) reports that "these reactions . . . were always controllable" by anti-Parkinson drugs alone.

3. Akathisia is a syndrome which occurs during the administration of high doses of tranquilizing drugs. Whenever a patient fails to respond to the administration of high doses of these medicines or when he seems to have a paradoxical effect from them, the possibility of akathisia should be considered and appropriate treatment instituted.

4. Appropriate treatment of the condition appears to be, at this time, a reduction or change in the tranquilizing drugs used, plus the addition of an anti-Parkinson drug such as Cogentin, Pagitane, or Kemadrin.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.